Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|July 27, 2024
Analysis of Carcinogenic Involvement of MicroRNA Pattern in Peripheral Non-Cancerous Tissues and Chronic Viral Liver InjuryTomohiro Umezu, Tomoya Mori, Hidenori Toyoda, et al.
Molecular Therapy. Nucleic Acids|March 30, 2026
Exosome-like nanovesicles from acerola for CRISPR-Cas9 ribonucleoprotein delivery to the central nervous systemYui Nagamatsu, Tomohiro Umezu, Taehun Hong, et al.
International Journal of Molecular Sciences|April 20, 2016
Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of ImatinibKazuma Ohyashiki, Tomohiro Umezu, Seiichiro Katagiri, et al.
Cancer Reports (Hoboken, N.J.)|December 26, 2023
Characterization of circulating miRNAs in the treatment of primary liver tumorsTomohiro Umezu, Shogo Tanaka, Shoji Kubo, et al.
Plos One|March 9, 2011
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphomaKazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, et al.
Molecular Therapy. Methods & Clinical Development|April 14, 2021
Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administrationTomohiro Umezu, Masakatsu Takanashi, Yoshiki Murakami, et al.
International Journal of Hematology|February 16, 2017
Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitorsMichiyo Asano, Tomohiro Umezu, Seiichiro Katagiri, et al.
Drug Design, Development and Therapy|June 27, 2019
A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndromeMichiyo Asano, Junko H Ohyashiki, Chiaki Kobayashi-Kawana, et al.
Journal of Clinical Medicine|October 30, 2020
Comprehensive Gene Analysis of IgG4-Related Ophthalmic Disease Using RNA SequencingMasaki Asakage, Yoshihiko Usui, Naoya Nezu, et al.
Scientific Reports|March 16, 2024
Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the CBP/β-catenin inhibitor PRI-724 in patients with liver cirrhosisMayu Yoshida, Juntaro Matsuzaki, Koji Fujita, et al.
Pageof 6